News

Strategic Research and Innovation Agenda on pandemic preparedness - Open for consultation

Published on | 2 months ago

Programmes Health

The Strategic Research and Innovation Agenda (SRIA) on pandemic preparedness is now open for public consultation. This document will guide the future European Partnership for Pandemic Preparedness, addressing research gaps and setting clear priorities for action.

Researchers, policymakers, stakeholders and the broader community are invited to review the draft SRIA and share their insights. 

The consultation is open until 15 December 2024 (8 pm CEST). 

Read the draft here: https://beready4pandemics.eu/sria
Access the survey here:
https://ec.europa.eu/eusurvey/runner/Public_Consultation_SRIA_PandemicPreparedness 


myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1528 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.